Readystate Asset Management LP Bristol Myers Squibb CO Call Options Transaction History

Readystate Asset Management LP

  • $5.36 Trillion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $4.2 Million - $5.48 Million
105,900 New
105,900 $5.48 Billion
Q1 2024

May 10, 2024
BUY
$47.98 - $54.4 $10.4 Million - $11.8 Million
217,100 Added 9868.18%
219,300 $11.9 Billion
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $106,656 - $127,270
2,200 New
2,200 $113 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email